Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruijuan Du

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The EMBO Journal|December 19, 2009
Rapid reprogramming of haemoglobin structure-function exposes multiple dual-antimicrobial potenciesRuijuan Du, Bow Ho, Jeak Ling Ding
Current Pharmaceutical Design|April 8, 2011
Application of cell-free hemolymph of horseshoe crab in antimicrobial drug screeningRuijuan Du, Bow Ho, Jeak Ling Ding
Journal of Leukocyte Biology|April 19, 2014
IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cellsRuijuan Du, Hua Zhao, Fan Yan, et al.
Microscopy Research and Technique|September 28, 2021
Bioinspiration of the vein structure of dragonfly wings on its flight characteristicsChao Liu, Ruijuan Du, Fadong Li, et al.
Plos One|February 2, 2023
Regional differences and threshold effects of labor transfer affecting the technical efficiency of China's agricultural industry: A case study of the apple industryYu Sun, Ruijuan Du, Xinmin Liu, et al.
American Journal of Clinical and Experimental Immunology|July 26, 2013
Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobinRuijuan Du, Imelda Winarsih, Bow Ho, et al.
Molecular Cancer|January 16, 2021
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapyRuijuan Du, Chuntian Huang, Kangdong Liu, et al.
Clinical Rheumatology|March 11, 2026
Novel genetic insights: Mendelian randomization implicates Felty Syndrome in atrial fibrillation riskRuijuan Du, Yanlong Zhang, Fei Cheng, et al.
Frontiers in Oncology|April 8, 2022
PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted TherapyQian Luo, Ruijuan Du, Wenting Liu, et al.
Gene|February 12, 2024
FSTL1: A double-edged sword in cancer developmentRuijuan Du, Kai Li, Kelei Guo, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The EMBO Journal|December 19, 2009
Rapid reprogramming of haemoglobin structure-function exposes multiple dual-antimicrobial potenciesRuijuan Du, Bow Ho, Jeak Ling Ding
Current Pharmaceutical Design|April 8, 2011
Application of cell-free hemolymph of horseshoe crab in antimicrobial drug screeningRuijuan Du, Bow Ho, Jeak Ling Ding
Journal of Leukocyte Biology|April 19, 2014
IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cellsRuijuan Du, Hua Zhao, Fan Yan, et al.
Microscopy Research and Technique|September 28, 2021
Bioinspiration of the vein structure of dragonfly wings on its flight characteristicsChao Liu, Ruijuan Du, Fadong Li, et al.
Plos One|February 2, 2023
Regional differences and threshold effects of labor transfer affecting the technical efficiency of China's agricultural industry: A case study of the apple industryYu Sun, Ruijuan Du, Xinmin Liu, et al.
American Journal of Clinical and Experimental Immunology|July 26, 2013
Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobinRuijuan Du, Imelda Winarsih, Bow Ho, et al.
Molecular Cancer|January 16, 2021
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapyRuijuan Du, Chuntian Huang, Kangdong Liu, et al.
Clinical Rheumatology|March 11, 2026
Novel genetic insights: Mendelian randomization implicates Felty Syndrome in atrial fibrillation riskRuijuan Du, Yanlong Zhang, Fei Cheng, et al.
Frontiers in Oncology|April 8, 2022
PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted TherapyQian Luo, Ruijuan Du, Wenting Liu, et al.
Gene|February 12, 2024
FSTL1: A double-edged sword in cancer developmentRuijuan Du, Kai Li, Kelei Guo, et al.
Pageof 4